Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

EPO 2021

G1/23: Irreproducibility alone does not exclude a product from the state of the art

Industry news News 02/07/2025

The Enlarged Board of Appeal of the European Patent Office (EPO) today issued its decision in case G1/23. This pivotal decision, arising from a case involving the commercially available polymer “ENGAGE® 8400”, directly addresses a critical question: Can a product on the market be excluded from the state of the art (within the meaning of Article 54(2) EPC) solely because its composition or internal structure can’t be reproduced by a person skilled in the art?

Read more
Dermot Medtech Rising 2023 Galway
European, Events, Team news 28/02/2024

Secerna to attend Dublin Tech Summit

Secerna To Attend North East Life Sciences Conference 2024
Events, News 27/02/2024

Secerna to attend North East Life Sciences Conference 2024

Where Does Ireland Sit In Terms Of Innovation
European, News 22/02/2024

Where Does Ireland Sit In Terms Of Innovation?

United States Patent And Trademark Office
Industry news, News 21/02/2024

USPTO Issues Guidance for AI-assisted Inventions

Secerna Website Images 2023 (27)
European, News 20/02/2024

EPO announces fee reductions for micro-entities

Jason
Events 20/02/2024

Secerna to attend Enterprise Investment Scheme Summit

European Parliament (1)
European, News 13/02/2024

Designing the future: EU Parliament proposes sweeping changes to European design protection

European Parliament
European, Industry news 08/02/2024

European Parliament seeks ban on patenting of gene-edited plants

Mrna Vaccines (1)
News 07/02/2024

Breaking Down the Code: Demystifying the Patent Battles Behind mRNA Vaccines

11 12 13 14 15 16 17 18 19 20 21